New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
DJUST Raises €12M to Simplify B2B Commerce Across Europe, UK and US
-
Form SC 13D/A IonQ, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Granica Launches Industry-first AI Efficiency Platform to Cut Cloud Data Costs up to 80% and Boost ROI from AI Initiatives
-
Instabase Doubles Valuation to $2B and Launches AI Hub, A Generative AI Based Platform for Content Understanding
-
Pionyr Immunotherapeutics’ Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023
-
Kira Learning Raises $15M Series A to Fuel National Expansion of its Platform to Empower K-12 Teachers and Students to Teach and Learn Computer Science
-
MBX Biosciences to Participate in Jefferies Healthcare Conference
-
Timescale Announces Corporate Rebrand Reflecting Company's Growth
-
Union.ai announces $19.1M Series A and launches all-new Union Cloud to simplify AI and data workflows for all
-
NEA Appoints Technology Investors Aaron Jacobson and Vanessa Larco to Senior Investing Team Roles; Lily Huang, Danielle Lay and Luke Pappas Promoted to Partner
-
X4 Pharmaceuticals (XFOR) Announces $65 Million Private Placement of Common Stock, Warrants
-
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
-
BluWave-Ai Expands EV Everywhere Commercial Adoption With Smartcar's Vehicle APIs
-
Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates
-
Orby AI Emerges from Stealth, Announces Funding to Build Generative AI Software That Learns What You Do and Does It For You
-
MBX Biosciences to Participate in May Investor Conferences
-
Minerva Surgical Reports First Quarter 2023 Financial Results
-
Concerned Shareholders of Cano Health (CANO) Issue Open Letter Regarding the Board’s Entrenchment Maneuvers and Latest Governance Failures
-
Concerned Shareholders of Cano Health Issue Open Letter Regarding the Board’s Entrenchment Maneuvers and Latest Governance Failures
-
Stablix and Vertex Establish Strategic Collaboration to Discover and Develop Targeted Protein Stabilization Therapeutics
-
Kindred, Members-Only Home Swapping Network, Announces 5,000 Nights Swapped and Series A Funding to Revolutionize the Sharing Economy
-
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
-
HEAVY.AI Launches HEAVY 7.0, Introducing Real-Time Machine Learning Capabilities
-
Relievant Medsystems Raises $50 Million to Advance the Treatment for Chronic Vertebrogenic Low Back Pain
-
Regulus Therapeutics (RGLS) Announces $15M Private Placement
-
Regulus Therapeutics Announces $15 Million Private Placement of Equity
-
Form SC 13D/A Berkshire Grey, Inc. Filed by: New Enterprise Associates 15, L.P.
-
MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
-
Harvard China Forum 2023 Includes Yida Gao of Shima Capital
-
Shima Capital Founder Yida Gao Teaching Crypto Finance Course at MIT
-
Shima Capital's Founder Yida Gao Teaches Crypto Finance Course at MIT
-
Form SC 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Perplexity AI Launches iOS Version of Conversational Answer Engine, Announces $25.6M Series A Round Led by NEA
-
First Annual Entrepreneurship Summit Presented by the Harvard Undergraduate Venture Capital Group: Agenda and Speakers
-
Gilead Sciences (GILD) and Pionyr Immunotherapeutics Change Exclusive Option Agreement
-
Pionyr Immunotherapeutics and Gilead Change Exclusive Option Agreement
-
Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results
-
FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring
-
Topia Celebrates Transformational Year with Strong Customer Growth & New Solutions to Help Companies Manage Dynamic Workforce Mobility
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
MBX Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
-
Topia Awarded New Patent for Machine Learning Models to Identify and Use Seasonality Trend Data
-
AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
-
Form SC 13D/A MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Stablix to Present at Wells Fargo 2023 Targeted Protein Degradation Summit
-
HEAVY.AI Teams with Bain, Maxar, and NVIDIA to Provide High-Fidelity Digital Twins for Telecom Networks
-
Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Minerva Surgical Closes $30 Million Private Placement of Common Stock

